Stocks

Trump’s Greenland Tariff Threats Push Gold and Silver to Record Highs

The global financial landscape shifted on Monday as investors abandoned traditional assets in favor of precious metals. Gold (XAUUSD) and…

Read More »

Big Banks Q4 Earnings Recap: Wall Street’s Powerhouses Navigate a Complex Landscape

Wall Street’s giants just finished pulling back the curtain on their fourth-quarter performances, revealing a sector that continues to capitalize…

Read More »

Why These Stocks Could Thrive Under Trump’s Housing Affordability Plan

The American housing market finally broke its silence this month. For over two years, high interest rates and inflated prices…

Read More »

Trump’s Proposed 10% Rate Cap Sends Credit Card Stocks Reeling as Fintech Alternatives Eye Opportunity

Wall Street’s banking giants and credit card specialists faced a harsh wake-up call Monday as shares plummeted following President Donald…

Read More »

Trump to Ban Big Wall Street Firms From Buying Single Family Homes

President Donald Trump sent shockwaves through the financial sector on Wednesday, announcing an immediate initiative to bar large institutional investors…

Read More »

How the White House Plans to Handle Venezuela’s Oil Moving Forward

The geopolitical landscape of the Western Hemisphere shifted on its axis this week as the United States began implementing a…

Read More »

Profusa Scales European Operations and Strengthens Balance Sheet Ahead of 2026 Commercial Launch

In a pivotal year-end strategic push, Profusa (NASDAQ: PFSA) announced two major milestones that signal a shift from a clinical-stage…

Read More »

Crude Awakening: Top Oil Stocks to Benefit From Overthrow of Venezuela’s Maduro

The sudden capture and extradition of Nicolas Maduro over the weekend triggered a massive rally across the energy sector on…

Read More »

Tech Stocks Slide as Renewed AI Valuation Anxiety Grips Wall Street

Wall Street witnessed a sharp reversal on Wednesday as the exuberant artificial intelligence trade hit a wall of skepticism. Investors…

Read More »

Profusa Hits Major Clinical Milestone in PAD Study, Targets European Commercial Launch in 2026

Profusa (NASDAQ: PFSA), a commercial-stage digital health company, solidified its position in the biochemical monitoring market this week after presenting…

Read More »
Back to top button